跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 461 条关于
“PINK1 activators”
全部
461
临床试验
224
药物
132
机构
2
资讯
103
去年
Progenra Discovers First-in-Class PINK1 Activators for Inherited Parkinson's Disease
去年
Conduit Pharmaceuticals Secures Japanese Patent for AZD1656 Glucokinase Activator Targeting Autoimmune Disorders
9个月前
Ovid Therapeutics Reports First-in-Human Safety Data for Novel KCC2 Direct Activator OV350
3个月前
Genetics of Parkinson Disease: Paradigm Shifts and Future Prospects
去年
MD Anderson Highlights: Modified NRF2 Activator Reverses Chronic Pain, Canakinumab Shows Promise in MDS Subgroup
去年
MD Anderson Research Highlights: Modified NRF2 Activator, Canakinumab in MDS, and More
10个月前
Windtree Therapeutics Strengthens Patent Portfolio for Heart Failure Drug Istaroxime with International Approvals
2个月前
Masked T-Cell Engagers and Pasritamig Raise New Hope for Advanced Prostate Cancer Immunotherapy
2年前
Jacobio Pharma Receives IND Approval for P53 Y220C Activator JAB-30355 in the US
5年前
Leading Biotech Companies Converge at Mitochondria-Targeted Drug Development Summit to Advance Therapeutic Pipeline
第 1 页,共 11 页
上一页
下一页